Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Q/C Technologies, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 20 | 23 | +3 |
| Shares | 917.9K | 62.0K | −855.8K (−93.2%) |
| Value | $1.38M | $114.6K | −$1.26M (−91.7%) |
New holders (6)
Institutions that held Q/C Technologies, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 14,410 | $26.5K | 0.00% |
| Virtu Financial LLC | 11,688 | $22.0K | 0.00% |
| Redwood Wealth Management Group, LLC | 50 | $92 | 0.00% |
| Tower Research Capital LLC (TRC) | 39 | $72 | 0.00% |
| Mather Group, LLC. | 17 | $41 | 0.00% |
| Anchor Investment Management, LLC | 1 | $2 | 0.00% |
Sold out (3)
Institutions that held Q/C Technologies, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 875,933 | $1.28M |
| Ancora Advisors, LLC | 90 | $215 |
| WR Wealth Planners, LLC | 34 | $81 |